A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure.
Phase of Trial: Phase III
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Bucindolol (Primary)
- Indications Heart failure
- Focus Registrational; Therapeutic Use
- Acronyms BEST
- 15 Nov 2017 Results assessing recovery of ventricular function in patients with chronic heart failure by taking patients data from BEST study, presented at the 90th Annual Scientific Sessions of the American Heart Association.
- 09 Sep 2015 Results of retrospective analysis of data to investigate effect of bucindolol in patients with atrial flutter were published in the Journal of Cardiac Failure and will be presented at the 19th Annual Scientific Meeting of the Heart Failure Society of America, according to an ARCA Biopharma Inc media release.
- 09 Sep 2015 Results of retrospective analysis of data to investigate effect of bucindolol in patients with atrial flutter published in the Media Release.